About Johnson & Johnson
Johnson & Johnson (JNJ) has been publicly traded since 1962, making it a 64-year-old public company. It operates in the Drug Manufacturers - General industry within the Healthcare sector. The company is headquartered in New Brunswick, United States and employs approximately 138,200 people. With a market capitalization of $582 billion, JNJ is one of the largest publicly traded companies.
Key Statistics
- Current Price
- $243.86
- Market Cap
- $587.68B
- 52-Week High
- $251.71
- 52-Week Low
- $141.50
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
$1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +18.46% | $205.86 | $243.86 |
| 2025 | +47.48% | $139.58 | $205.86 |
| 2024 | -4.81% | $146.64 | $139.58 |
| 2023 | -8.58% | $160.40 | $146.64 |
| 2022 | +5.97% | $151.35 | $160.40 |
| 2021 | +11.44% | $135.82 | $151.35 |
| 2020 | +10.82% | $122.55 | $135.82 |
| 2019 | +16.22% | $105.45 | $122.55 |
| 2018 | -5.13% | $111.15 | $105.45 |
| 2017 | +24.43% | $89.33 | $111.15 |
| 2016 | +15.33% | $77.46 | $89.33 |
| 2015 | +1.14% | $76.59 | $77.46 |
| 2014 | +17.34% | $65.27 | $76.59 |
| 2013 | +34.62% | $48.48 | $65.27 |
| 2012 | +10.85% | $43.74 | $48.48 |
| 2011 | +9.89% | $39.80 | $43.74 |
| 2010 | -0.59% | $40.04 | $39.80 |
| 2009 | +11.27% | $35.98 | $40.04 |
| 2008 | -7.72% | $38.99 | $35.98 |
| 2007 | +3.61% | $37.63 | $38.99 |
| 2006 | +12.43% | $33.47 | $37.63 |
| 2005 | -3.36% | $34.63 | $33.47 |
| 2004 | +25.17% | $27.67 | $34.63 |
| 2003 | -2.08% | $28.26 | $27.67 |
| 2002 | -7.88% | $30.67 | $28.26 |
| 2001 | +14.00% | $26.91 | $30.67 |
| 2000 | +14.25% | $23.55 | $26.91 |
| 1999 | +12.47% | $20.94 | $23.55 |
| 1998 | +28.98% | $16.23 | $20.94 |
| 1997 | +34.29% | $12.09 | $16.23 |
| 1996 | +18.10% | $10.24 | $12.09 |
| 1995 | +59.12% | $6.43 | $10.24 |
| 1994 | +25.05% | $5.14 | $6.43 |
| 1993 | -8.97% | $5.65 | $5.14 |
| 1992 | -10.19% | $6.29 | $5.65 |
| 1991 | +62.31% | $3.88 | $6.29 |
| 1990 | +23.41% | $3.14 | $3.88 |
| 1989 | +42.64% | $2.20 | $3.14 |
| 1988 | +16.51% | $1.89 | $2.20 |
| 1987 | +16.27% | $1.63 | $1.89 |
| 1986 | +27.43% | $1.28 | $1.63 |
| 1985 | +49.84% | $0.85 | $1.28 |
| 1984 | -8.54% | $0.93 | $0.85 |
| 1983 | -15.67% | $1.10 | $0.93 |
| 1982 | +36.88% | $0.81 | $1.10 |
| 1981 | +14.51% | $0.70 | $0.81 |
| 1980 | +29.42% | $0.54 | $0.70 |
| 1979 | +10.51% | $0.49 | $0.54 |
| 1978 | -1.76% | $0.50 | $0.49 |
| 1977 | +0.43% | $0.50 | $0.50 |
| 1976 | -12.03% | $0.57 | $0.50 |
| 1975 | +12.02% | $0.51 | $0.57 |
| 1974 | -27.72% | $0.70 | $0.51 |
| 1973 | -13.22% | $0.81 | $0.70 |
| 1972 | +32.99% | $0.61 | $0.81 |
| 1971 | +73.71% | $0.35 | $0.61 |
| 1970 | -4.33% | $0.37 | $0.35 |
| 1969 | +70.16% | $0.21 | $0.37 |
| 1968 | +16.96% | $0.18 | $0.21 |
| 1967 | +62.32% | $0.11 | $0.18 |
| 1966 | +0.20% | $0.11 | $0.11 |
| 1965 | +55.80% | $0.07 | $0.11 |
| 1964 | +10.80% | $0.07 | $0.07 |
| 1963 | +41.00% | $0.05 | $0.07 |
Valuation
JNJ currently trades at a trailing P/E ratio of 21.9, which is considered moderate relative to the broader market. The forward P/E of 19.2 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 7.1. The price-to-sales ratio is 6.2.
Dividends
Johnson & Johnson pays a dividend to shareholders with a current yield of 2.15%. This translates to $5.20 per share annually. The payout ratio of 47% indicates sustainable dividend coverage.
Risk & Volatility
JNJ has a beta of 0.33, indicating it is less volatile than the overall market. The stock's 52-week range is $141.50 to $251.71, and it currently trades near its 52-week high.
Analyst Ratings
Based on 24 analyst opinions, JNJ has a consensus "buy" rating. The average price target of $238.29 suggests 1.3% downside from current levels.
Frequently Asked Questions
What does Johnson & Johnson do? ▼
Johnson & Johnson is a Drug Manufacturers - General company operating in the Healthcare sector. The company is headquartered in New Brunswick, United States.
What sector is JNJ in? ▼
JNJ operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
When did JNJ go public? ▼
Johnson & Johnson went public in 1962, making it a 64-year-old public company as of 2026.
How much would $1,000 invested in JNJ 5 years ago be worth today? ▼
A $1,000 investment in JNJ five years ago would be worth approximately $1,781 today, representing a 78.1% return.
Does JNJ pay dividends? ▼
Yes, Johnson & Johnson pays a dividend with a current yield of 2.15%, which is $5.2 per share annually.
What is JNJ's market cap? ▼
Johnson & Johnson has a market capitalization of $582 billion, classifying it as a mega-cap company.
What is JNJ's P/E ratio? ▼
JNJ has a trailing P/E ratio of 21.9 and a forward P/E of 19.2, which measures how much investors are paying per dollar of earnings.
Is JNJ a buy, hold, or sell? ▼
Based on 24 opinions, JNJ has a consensus "buy" rating. The average price target is $238.29.
Last updated: 3/14/2026